$3.94 Billion is the total value of Rock Springs Capital Management LP's 148 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 24.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $148,819,000 | +97.3% | 625,000 | -4.0% | 3.78% | +82.5% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $140,922,000 | -15.5% | 1,465,500 | +7.2% | 3.58% | -21.8% |
| IMMU | Sell | IMMUNOMEDICS INC | $134,985,000 | +127.0% | 1,587,500 | -5.4% | 3.42% | +110.0% |
| UNH | UNITEDHEALTH GROUP INC | $126,267,000 | +5.7% | 405,000 | 0.0% | 3.20% | -2.2% | |
| HUM | Buy | HUMANA INC | $100,368,000 | +35.5% | 242,500 | +27.0% | 2.55% | +25.4% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $88,322,000 | +17.9% | 952,773 | -0.8% | 2.24% | +9.1% |
| ISRG | INTUITIVE SURGICAL INC | $85,145,000 | +24.5% | 120,000 | 0.0% | 2.16% | +15.1% | |
| CNC | Buy | CENTENE CORP DEL | $76,996,000 | -7.9% | 1,320,000 | +0.4% | 1.95% | -14.7% |
| ARGX | ARGENX SEsponsored adr | $75,475,000 | +16.6% | 287,500 | 0.0% | 1.92% | +7.8% | |
| PODD | Buy | INSULET CORP | $74,644,000 | +31.1% | 315,500 | +7.7% | 1.89% | +21.3% |
| ZLAB | Buy | ZAI LAB LTDadr | $68,493,000 | +2.5% | 823,527 | +1.3% | 1.74% | -5.1% |
| NVTA | Buy | INVITAE CORP | $65,804,000 | +43.8% | 1,517,962 | +0.5% | 1.67% | +33.1% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $64,895,000 | +26.9% | 1,573,200 | +49.1% | 1.65% | +17.4% |
| NVAX | Buy | NOVAVAX INC | $63,461,000 | +33.4% | 585,705 | +2.6% | 1.61% | +23.5% |
| HCA | Sell | HCA HEALTHCARE INC | $62,340,000 | +16.9% | 500,000 | -9.0% | 1.58% | +8.1% |
| BGNE | BEIGENE LTDsponsored adr | $61,585,000 | +52.0% | 215,000 | 0.0% | 1.56% | +40.7% | |
| PCRX | Buy | PACIRA BIOSCIENCES | $60,421,000 | +24.5% | 1,005,000 | +8.6% | 1.53% | +15.2% |
| MRTX | MIRATI THERAPEUTICS INC | $57,912,000 | +45.4% | 348,761 | 0.0% | 1.47% | +34.5% | |
| FRPT | Buy | FRESHPET INC | $56,551,000 | +42.0% | 506,500 | +6.4% | 1.44% | +31.4% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $55,353,000 | -12.3% | 1,581,509 | +34.1% | 1.40% | -18.9% |
| NVRO | NEVRO CORP | $53,770,000 | +16.6% | 386,000 | 0.0% | 1.36% | +7.8% | |
| BAX | BAXTER INTL INC | $51,871,000 | -6.6% | 645,000 | 0.0% | 1.32% | -13.6% | |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $50,492,000 | – | 650,000 | +100.0% | 1.28% | – |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $49,477,000 | -3.2% | 339,814 | -1.5% | 1.26% | -10.5% |
| IDXX | IDEXX LABS INC | $49,139,000 | +19.1% | 125,000 | 0.0% | 1.25% | +10.2% | |
| BIIB | Sell | BIOGEN INC | $48,935,000 | +1.6% | 172,500 | -4.2% | 1.24% | -6.0% |
| SGEN | SEATTLE GENETICS INC | $48,923,000 | +15.2% | 250,000 | 0.0% | 1.24% | +6.5% | |
| SRPT | SAREPTA THERAPEUTICS INC | $48,519,000 | -12.4% | 345,500 | 0.0% | 1.23% | -19.0% | |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $47,411,000 | -6.3% | 576,841 | -10.8% | 1.20% | -13.3% |
| ALGN | ALIGN TECHNOLOGY INC | $46,812,000 | +19.3% | 143,000 | 0.0% | 1.19% | +10.4% | |
| EW | EDWARDS LIFESCIENCES CORP | $46,455,000 | +15.5% | 582,000 | 0.0% | 1.18% | +6.9% | |
| EHC | Sell | ENCOMPASS HEALTH CORP | $45,356,000 | -12.0% | 698,000 | -16.2% | 1.15% | -18.6% |
| TFX | TELEFLEX INCORPORATED | $44,255,000 | -6.5% | 130,000 | 0.0% | 1.12% | -13.5% | |
| EXAS | EXACT SCIENCES CORP | $43,227,000 | +17.3% | 424,000 | 0.0% | 1.10% | +8.5% | |
| BSX | BOSTON SCIENTIFIC CORP | $42,031,000 | +8.8% | 1,100,000 | 0.0% | 1.07% | +0.7% | |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $36,034,000 | +14.1% | 233,500 | +9.4% | 0.91% | +5.5% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $35,107,000 | -20.1% | 1,885,428 | +0.4% | 0.89% | -26.1% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $30,880,000 | +11.0% | 635,000 | +10.4% | 0.78% | +2.8% |
| PEN | Sell | PENUMBRA INC | $30,906,000 | -16.5% | 159,000 | -23.2% | 0.78% | -22.8% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $30,544,000 | -15.6% | 1,665,449 | -17.8% | 0.78% | -21.9% |
| INSP | Sell | INSPIRE MED SYS INC | $30,456,000 | +32.1% | 236,000 | -10.9% | 0.77% | +22.1% |
| EPZM | Buy | EPIZYME INC | $30,441,000 | -9.9% | 2,551,659 | +21.3% | 0.77% | -16.7% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $30,189,000 | +4.8% | 254,268 | 0.0% | 0.77% | -3.0% | |
| CVET | Buy | COVETRUS INC | $29,890,000 | +99.5% | 1,225,000 | +46.3% | 0.76% | +84.4% |
| INCY | Buy | INCYTE CORP | $26,922,000 | +3.6% | 300,000 | +20.0% | 0.68% | -4.2% |
| ARDX | Buy | ARDELYX INC | $26,654,000 | -23.2% | 5,076,867 | +1.2% | 0.68% | -29.0% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $26,628,000 | -44.3% | 350,000 | -9.7% | 0.68% | -48.4% |
| IMVT | Buy | IMMUNOVANT INC | $26,127,000 | +137.2% | 742,449 | +64.1% | 0.66% | +119.5% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $25,747,000 | +25.0% | 225,000 | +22.6% | 0.65% | +15.6% |
| HCAT | Buy | HEALTH CATALYST INC | $25,730,000 | +107.6% | 703,000 | +65.4% | 0.65% | +92.1% |
| PHR | Buy | PHREESIA INC | $25,704,000 | +39.5% | 800,000 | +22.8% | 0.65% | +29.1% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $25,583,000 | -0.4% | 1,327,614 | +0.6% | 0.65% | -7.9% |
| BFAM | Buy | BRIGHT HORIZONS FAM SOL IN D | $25,163,000 | +118.0% | 165,500 | +68.0% | 0.64% | +101.3% |
| GLPG | GALAPAGOS NVspon adr | $24,834,000 | -28.1% | 175,000 | 0.0% | 0.63% | -33.5% | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $24,464,000 | +19.0% | 1,175,000 | 0.0% | 0.62% | +10.1% | |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $24,067,000 | -31.1% | 1,463,915 | -2.3% | 0.61% | -36.3% |
| INZY | New | INOZYME PHARMA INC | $23,134,000 | – | 879,954 | +100.0% | 0.59% | – |
| KYMR | New | KYMERA THERAPEUTICS INC | $22,939,000 | – | 709,965 | +100.0% | 0.58% | – |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $22,405,000 | -0.9% | 760,000 | -15.6% | 0.57% | -8.4% |
| GH | GUARDANT HEALTH INC | $21,238,000 | +37.8% | 190,000 | 0.0% | 0.54% | +27.4% | |
| MNTA | MOMENTA PHARMACEUTICALS INC | $20,992,000 | +57.7% | 400,000 | 0.0% | 0.53% | +46.0% | |
| APLT | APPLIED THERAPEUTICS INC | $20,585,000 | -42.6% | 991,573 | 0.0% | 0.52% | -46.9% | |
| RPRX | Sell | ROYALTY PHARMA PLC | $20,404,000 | -15.9% | 485,000 | -3.0% | 0.52% | -22.2% |
| ATHA | New | ATHIRA PHARMA INC | $20,356,000 | – | 1,102,702 | +100.0% | 0.52% | – |
| ALLK | Buy | ALLAKOS INC | $19,677,000 | +14.6% | 241,582 | +1.1% | 0.50% | +5.9% |
| NVCR | NOVOCURE LTD | $19,479,000 | +87.7% | 175,000 | 0.0% | 0.49% | +73.3% | |
| PPD | Buy | PPD INC | $19,420,000 | +48.6% | 525,000 | +7.7% | 0.49% | +37.7% |
| RTRX | RETROPHIN INC | $18,908,000 | -9.6% | 1,024,261 | 0.0% | 0.48% | -16.2% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $18,874,000 | -16.7% | 244,106 | +20.1% | 0.48% | -23.0% |
| HQY | Buy | HEALTHEQUITY INC | $18,498,000 | -1.5% | 360,100 | +12.5% | 0.47% | -8.9% |
| CGEN | Buy | COMPUGEN LTDord | $18,408,000 | +8.4% | 1,132,775 | +0.2% | 0.47% | +0.2% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $18,314,000 | -43.1% | 4,350,000 | -6.5% | 0.46% | -47.3% |
| TGTX | TG THERAPEUTICS INC | $18,275,000 | +37.4% | 682,926 | 0.0% | 0.46% | +27.1% | |
| CYTOKINETICS INCnote 4.000%11/1 | $17,795,000 | -6.7% | 8,000,000 | 0.0% | 0.45% | -13.6% | ||
| RLAY | New | RELAY THERAPEUTICS INC | $17,618,000 | – | 413,674 | +100.0% | 0.45% | – |
| SWAV | Buy | SHOCKWAVE MED INC | $16,676,000 | +78.2% | 220,000 | +11.4% | 0.42% | +64.6% |
| NKTX | New | NKARTA INC | $16,259,000 | – | 540,873 | +100.0% | 0.41% | – |
| GOSSAMER BIO INCnote 5.000% 6/0 | $16,049,000 | +1.9% | 15,573,000 | 0.0% | 0.41% | -5.8% | ||
| OSH | New | OAK STR HEALTH INC | $16,032,000 | – | 300,000 | +100.0% | 0.41% | – |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $15,856,000 | -20.3% | 1,986,910 | 0.0% | 0.40% | -26.4% | |
| QURE | Buy | UNIQURE NV | $15,227,000 | -17.0% | 413,433 | +1.5% | 0.39% | -23.3% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $14,456,000 | -5.7% | 1,023,821 | +0.7% | 0.37% | -12.8% |
| CNMD | CONMED CORP | $14,161,000 | +9.3% | 180,000 | 0.0% | 0.36% | +1.1% | |
| SPRO | Buy | SPERO THERAPEUTICS INC | $13,797,000 | +65.8% | 1,236,256 | +101.0% | 0.35% | +53.5% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $13,025,000 | +115.1% | 423,040 | +74.1% | 0.33% | +98.8% |
| FGEN | Sell | FIBROGEN INC | $12,718,000 | -0.5% | 309,287 | -2.0% | 0.32% | -8.0% |
| ACCD | New | ACCOLADE INC | $12,633,000 | – | 325,000 | +100.0% | 0.32% | – |
| APRE | APREA THERAPEUTICS INC | $12,470,000 | -38.0% | 518,290 | 0.0% | 0.32% | -42.6% | |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $12,183,000 | -29.9% | 824,018 | -0.5% | 0.31% | -35.2% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $11,603,000 | -21.2% | 119,188 | -0.7% | 0.29% | -27.2% |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $11,389,000 | -30.4% | 947,541 | +1.1% | 0.29% | -35.6% |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $11,380,000 | – | 772,569 | +100.0% | 0.29% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $11,383,000 | +5.5% | 4,742,891 | -19.6% | 0.29% | -2.4% |
| ARVN | ARVINAS INC | $11,367,000 | -29.6% | 481,468 | 0.0% | 0.29% | -35.0% | |
| OSW | ONESPAWORLD HOLDINGS LIMITED | $11,310,000 | +36.3% | 1,740,000 | 0.0% | 0.29% | +25.9% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $11,277,000 | -23.3% | 1,590,528 | 0.0% | 0.29% | -29.2% | |
| Buy | TRILLIUM THERAPEUTICS INC | $10,955,000 | +77.6% | 770,918 | +1.1% | 0.28% | +64.5% | |
| TARA | New | PROTARA THERAPEUTICS INC | $10,832,000 | – | 643,622 | +100.0% | 0.28% | – |
| PRLD | New | PRELUDE THERAPEUTICS INC | $10,855,000 | – | 360,263 | +100.0% | 0.28% | – |
| CNST | CONSTELLATION PHARMCETICLS I | $10,448,000 | -32.6% | 515,680 | 0.0% | 0.26% | -37.6% | |
| PRTA | Buy | PROTHENA CORP PLC | $10,242,000 | -1.0% | 1,025,207 | +3.6% | 0.26% | -8.5% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $10,057,000 | -11.9% | 464,086 | -9.4% | 0.26% | -18.5% |
| TXG | 10X GENOMICS INC | $9,476,000 | +39.6% | 76,000 | 0.0% | 0.24% | +29.0% | |
| CHMA | Buy | CHIASMA INC | $9,220,000 | +23.1% | 2,144,225 | +54.0% | 0.23% | +14.1% |
| RDUS | Sell | RADIUS HEALTH INC | $9,233,000 | -32.5% | 814,208 | -18.8% | 0.23% | -37.6% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $9,053,000 | +4.8% | 1,673,414 | +1.1% | 0.23% | -3.0% |
| NRIX | New | NURIX THERAPEUTICS INC | $8,990,000 | – | 257,514 | +100.0% | 0.23% | – |
| TBIO | Sell | TRANSLATE BIO INC | $8,746,000 | -26.2% | 642,646 | -2.8% | 0.22% | -31.7% |
| GMDA | GAMIDA CELL LTD | $8,369,000 | -9.2% | 2,016,656 | 0.0% | 0.21% | -16.2% | |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $8,199,000 | – | 57,500 | +100.0% | 0.21% | – |
| XENT | INTERSECT ENT INC | $8,155,000 | +20.5% | 500,000 | 0.0% | 0.21% | +11.3% | |
| WST | Sell | WEST PHARMACEUTICAL SVSC INC | $7,835,000 | -51.4% | 28,500 | -59.9% | 0.20% | -55.0% |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $7,784,000 | -11.2% | 252,138 | +22.5% | 0.20% | -17.5% |
| ZGNX | ZOGENIX INC | $7,459,000 | -33.6% | 415,982 | 0.0% | 0.19% | -38.6% | |
| IMRA | Sell | IMARA INC | $7,301,000 | -27.6% | 358,943 | -1.6% | 0.18% | -33.0% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $7,204,000 | -31.3% | 512,711 | +0.8% | 0.18% | -36.5% |
| ANNX | New | ANNEXON INC | $7,159,000 | – | 236,811 | +100.0% | 0.18% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $7,119,000 | -51.7% | 1,647,920 | -0.7% | 0.18% | -55.2% |
| MGNX | Buy | MACROGENICS INC | $6,616,000 | +1.0% | 262,641 | +12.0% | 0.17% | -6.7% |
| ODT | Buy | ODONATE THERAPEUTICS INC | $6,573,000 | -64.5% | 489,432 | +11.9% | 0.17% | -67.1% |
| INSMED INCnote 1.750% 1/1 | $6,541,000 | +11.6% | 6,000,000 | 0.0% | 0.17% | +3.1% | ||
| BCEL | New | ATRECA INC | $6,298,000 | – | 450,830 | +100.0% | 0.16% | – |
| NGM | Buy | NGM BIOPHARMACEUTICALS INC | $5,735,000 | -18.7% | 360,454 | +0.9% | 0.15% | -24.7% |
| XENE | XENON PHARMACEUTICALS INC | $5,709,000 | -11.7% | 515,711 | 0.0% | 0.14% | -18.1% | |
| ITOS | New | ITEOS THERAPEUTICS INC | $5,592,000 | – | 226,681 | +100.0% | 0.14% | – |
| GDRX | New | GOODRX HLDGS INC | $5,560,000 | – | 100,000 | +100.0% | 0.14% | – |
| ACRX | New | ACELRX PHARMACEUTICALS INC | $5,358,000 | – | 3,773,585 | +100.0% | 0.14% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $5,336,000 | +100.4% | 2,076,307 | +26.3% | 0.14% | +84.9% |
| GRTX | GALERA THERAPEUTICS INC | $5,131,000 | +26.6% | 567,552 | 0.0% | 0.13% | +17.1% | |
| PANAU | New | PANACEA ACQUISITION CORPunit 99/99/9999 | $4,825,000 | – | 402,088 | +100.0% | 0.12% | – |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $4,609,000 | -12.4% | 1,313,174 | +14.8% | 0.12% | -18.8% |
| ANAB | Buy | ANAPTYSBIO INC | $4,559,000 | -33.5% | 309,113 | +0.8% | 0.12% | -38.3% |
| CYTK | Buy | CYTOKINETICS INC | $4,471,000 | +145.0% | 206,495 | +166.7% | 0.11% | +126.0% |
| OBSV | Buy | OBSEVA SA | $3,558,000 | -57.6% | 1,434,652 | +0.8% | 0.09% | -60.9% |
| PSTX | New | POSEIDA THERAPEUTICS INC | $3,260,000 | – | 367,499 | +100.0% | 0.08% | – |
| CO | Sell | GLOBAL CORD BLOOD CORPORATIO | $3,203,000 | +11.7% | 904,800 | -2.2% | 0.08% | +2.5% |
| RETROPHIN INCnote 2.500% 9/1 | $2,779,000 | +2.4% | 3,250,000 | 0.0% | 0.07% | -4.1% | ||
| PASG | Buy | PASSAGE BIO INC | $2,701,000 | -51.4% | 206,036 | +1.3% | 0.07% | -54.9% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $2,449,000 | -93.3% | 9,000 | -92.8% | 0.06% | -93.8% |
| IGMS | Sell | IGM BIOSCIENCES INC | $1,459,000 | -79.0% | 19,762 | -79.3% | 0.04% | -80.6% |
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,385,000 | -17.2% | 1,000,000 | 0.0% | 0.04% | -23.9% | ||
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,320,000 | -9.6% | 1,500,000 | 0.0% | 0.03% | -17.5% | ||
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,244,000 | +12.6% | 1,500,000 | 0.0% | 0.03% | +6.7% | ||
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $1,276,000 | -48.6% | 271,585 | -33.2% | 0.03% | -52.9% |
| PACIRA BIOSCIENCESnote 2.375% 4/0 | $1,151,000 | +5.2% | 1,000,000 | 0.0% | 0.03% | -3.3% | ||
| NEVRO CORPnote 2.750% 4/0 | $775,000 | +13.5% | 500,000 | 0.0% | 0.02% | +5.3% | ||
| NABRIVA THERAPEUTICS PLC | $569,000 | -21.0% | 1,067,664 | 0.0% | 0.01% | -30.0% | ||
| BMYRT | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $417,000 | -37.1% | 185,150 | 0.0% | 0.01% | -38.9% | |
| NARI | Exit | INARI MED INC | $0 | – | -80,000 | -100.0% | -0.11% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -351,638 | -100.0% | -0.15% | – |
| BNR | Exit | BURNING ROCK BIOTECH LTDsponsored ads | $0 | – | -200,000 | -100.0% | -0.15% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -696,115 | -100.0% | -0.20% | – |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -130,000 | -100.0% | -0.22% | – |
| RPTX | Exit | REPARE THERAPEUTICS INC | $0 | – | -274,815 | -100.0% | -0.23% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -209,829 | -100.0% | -0.34% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -105,000 | -100.0% | -0.40% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -203,817 | -100.0% | -0.41% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -172,716 | -100.0% | -0.46% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -288,279 | -100.0% | -0.50% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -440,468 | -100.0% | -0.52% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -126,000 | -100.0% | -0.82% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -161,000 | -100.0% | -0.83% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -2,306,196 | -100.0% | -1.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.